Related Experiment Video

Updated: May 20, 2026

Isolation and Physiological Analysis of Mouse Cardiomyocytes
11:02

Isolation and Physiological Analysis of Mouse Cardiomyocytes

Published on: September 7, 2014

Insights into restrictive cardiomyopathy from clinical and animal studies

Pierre-Yves Jean-Charles1, Yue-Jin Li, Chang-Long Nan

  • 1Department of Biomedical Science, College of Medicine, Florida Atlantic University, 777 Glades Road, Boca Raton, FL 33431, USA.

Journal of Geriatric Cardiology : JGC
|July 12, 2012
PubMed

Insights

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease with poor prognosis and unclear mechanisms. This review synthesizes recent clinical and animal model research to advance understanding and treatment of RCM.

Area of Science:

  • Cardiology
  • Genetics
  • Molecular Biology

Background:

  • Cardiomyopathies are myocardial diseases causing cardiac dysfunction and heart failure.
  • Restrictive cardiomyopathy (RCM) is the least common and studied type, with a poor prognosis.
  • Molecular mechanisms and effective treatments for RCM remain unclear.

Purpose of the Study:

  • To review recent clinical and translational research on restrictive cardiomyopathy (RCM).
  • To enhance understanding of RCM's underlying mechanisms, etiology, and development.
  • To inform the design of improved RCM treatments.

Main Methods:

  • Review of recent clinical studies on restrictive cardiomyopathy.
  • Analysis of translational studies using diseased transgenic animal models of RCM.

Main Results:

  • Synthesized current knowledge on RCM from clinical and translational research.
  • Highlighted gaps in understanding RCM's molecular mechanisms and progression.
  • Identified potential avenues for therapeutic development.

Conclusions:

  • Further research integrating clinical and translational findings is crucial for RCM.
  • A deeper understanding of RCM mechanisms is needed for effective treatment strategies.
  • Progress in RCM research offers hope for improved patient outcomes.

Keywords:
etiologymyocardial gene mutationrestrictive cardiomyopathytransgenic mice

More Related Videos

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction08:31

Isolation of Atrial Cardiomyocytes from a Rat Model of Metabolic Syndrome-related Heart Failure with Preserved Ejection Fraction

Published on: July 26, 2018

An Intact Pericardium Ischemic Rodent Model07:15

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...